SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,883,000 | +325.1% | 125,731 | +245.2% | 0.00% | – |
| Q1 2016 | $443,000 | -21.2% | 36,424 | +3.1% | 0.00% | -100.0% |
| Q4 2015 | $562,000 | -37.8% | 35,343 | -40.0% | 0.00% | 0.0% |
| Q3 2015 | $904,000 | -78.4% | 58,944 | -65.8% | 0.00% | -75.0% |
| Q2 2015 | $4,194,000 | +111.6% | 172,535 | +102.4% | 0.00% | +100.0% |
| Q1 2015 | $1,982,000 | -2.9% | 85,247 | +4.9% | 0.00% | 0.0% |
| Q4 2014 | $2,041,000 | +411.5% | 81,295 | +533.0% | 0.00% | – |
| Q3 2014 | $399,000 | +17.7% | 12,843 | -2.1% | 0.00% | – |
| Q2 2014 | $339,000 | +8.3% | 13,114 | -2.1% | 0.00% | – |
| Q1 2014 | $313,000 | -18.1% | 13,400 | -11.0% | 0.00% | – |
| Q4 2013 | $382,000 | -83.6% | 15,055 | -86.8% | 0.00% | -100.0% |
| Q3 2013 | $2,328,000 | +31.5% | 114,098 | +35.3% | 0.00% | 0.0% |
| Q2 2013 | $1,770,000 | – | 84,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|